Evidence of Pre-mortem Opioid Use among Fentanyl Overdose Decedents in a Safety Net Healthcare System (original) (raw)

Abstract

The rapid increase in fentanyl overdose deaths, particularly those also attributed to stimulants, has led to concerns about unintentional fentanyl exposure. Utilizing vital and medical record data, we identified overdose decedents from 2018 to 2021 in San Francisco who received care in the safety net system in the 3 years preceding death. Among 506 decedents, medical record evidence of pre-mortem opioid use was present for 48% of stimulant-only, 56% of stimulant-fentanyl, 65% of fentanyl-only, and 82% of non-fentanyl opioid decedents (p<0.001). Among stimulant-fentanyl decedents, an increase in 10 years of age (adjusted odds ratio (aOR) 0.74 [95% CI:0.59–0.94]) and race other than White or Black (aOR 0.36 [95% CI:0.15–0.87]) had lower odds of evidence of pre-mortem opioid use. While not conclusive, these findings raise the possibility that a significant proportion of fentanyl overdose decedents in San Francisco may have not intended to consume an opioid on the occasion of their death.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013-2019. MMWR Morb Mortal Wkly Rep 2021;70(6):202–7.
    Article Google Scholar
  2. Centers for Disease Control and Prevention. National Center for Health Statistics Mortality Data on CDC Wonder. Available at: https://wonder.cdc.gov/mcd.html. Published 2021. Accessed 2 Oct 2021.
  3. Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction 2003;98(6):739–47.
    Article Google Scholar
  4. Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344–50.
    Article Google Scholar
  5. Centers for Disease Control and Prevention. Rising Numbers of Deaths Involving Fentanyl and Fentanyl Analogs, Including Carfentanil, and Increased Usage and Mixing with Non-opioids. Available at: https://emergency.cdc.gov/han/HAN00413.asp. Published 2018. Accessed 4 Dec 2021.
  6. Nolan ML, Shamasunder S, Colon-Berezin C, Kunins HV, Paone D. Increased presence of fentanyl in cocaine-involved fatal overdoses: implications for prevention. J Urban Health 2019;96(1):49–54.
    Article Google Scholar
  7. Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend 2018;190:242–5.
    Article Google Scholar
  8. Bauer LK, Brody JK, Leon C, Baggett TP. Characteristics of homeless adults who died of drug overdose: a retrospective record review. J Health Care Poor Underserved 2016;27(2):846–59.
    Article Google Scholar
  9. Kral AH, Lambdin BH, Browne EN, et al. Transition from injecting opioids to smoking fentanyl in San Francisco, California. Drug Alcohol Depend 2021;227:109003.
    Article Google Scholar

Download references

Acknowledgements

This project was supported by NIDA grant K24DA042720 and CDC grant R01CE003364.

Author information

Authors and Affiliations

  1. San Francisco Department of Public Health, 25 Van Ness Avenue, Ste. 500, San Francisco, CA, 94102, USA
    Phillip O. Coffin & Vanessa M. McMahan
  2. University of California San Francisco, 500 Parnassus Ave, San Francisco, CA, 94143, USA
    Phillip O. Coffin & Ciaran Murphy

Authors

  1. Phillip O. Coffin
    You can also search for this author inPubMed Google Scholar
  2. Vanessa M. McMahan
    You can also search for this author inPubMed Google Scholar
  3. Ciaran Murphy
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toPhillip O. Coffin.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix

Appendix

Table 2 Characteristics of stimulant and opioid decedents in and out of safety net care

Full size table

Table 3 Demographic characteristics, evidence of pre-mortem opioid use, and involvement of a benzodiazepine in death among deaths that only involved a stimulant (_n_=140)

Full size table

Table 4 Demographic characteristics, evidence of pre-mortem opioid use, and involvement of a benzodiazepine in death among deaths that only involved a stimulant and fentanyl (_n_=220)

Full size table

Table 5 Demographic characteristics, evidence of pre-mortem opioid use, and involvement of a benzodiazepine in death among deaths that only involved another opioid (not fentanyl) (_n_=112)

Full size table

Table 6 Proportion of decedents with evidence of pre-mortem opioid use by substances involved in death and demographics (n=506)

Full size table

Table 7 Results of multivariable logistic regression analysis of demographic characteristics associated with evidence of opioid use in 3 years preceding death among stimulant-fentanyl decedents (_n_=220)

Full size table

Table 8 Results of multivariable logistic regression analysis of demographic characteristics associated with evidence of clinical history of opioid use in 3 years preceding death among fentanyl deaths (_n_=254)

Full size table

Rights and permissions

About this article

Cite this article

Coffin, P.O., McMahan, V.M. & Murphy, C. Evidence of Pre-mortem Opioid Use among Fentanyl Overdose Decedents in a Safety Net Healthcare System.J Urban Health 99, 865–872 (2022). https://doi.org/10.1007/s11524-022-00663-1

Download citation

Keywords